Literature DB >> 18621970

Pharmacogenetic study of 5,10-methylenetetrahydrofolate reductase C677T and thymidylate synthase 3R/2R gene polymorphisms and methotrexate-related toxicity in Chinese Han patients with inflammatory arthritis.

Q-Y Zeng, Y-K Wang, Z-Y Xiao, S-B Chen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18621970     DOI： 10.1136/ard.2007.085266

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  3 in total

Review 1.  Pharmacogenetics: can genes determine treatment efficacy and safety in JIA?

Authors:  Heinrike Schmeling; Gerd Horneff; Susanne M Benseler; Marvin J Fritzler
Journal:  Nat Rev Rheumatol       Date:  2014-08-12       Impact factor: 20.543

2.  Genetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patients.

Authors:  S A Owen; S L Hider; P Martin; I N Bruce; A Barton; W Thomson
Journal:  Pharmacogenomics J       Date:  2012-03-27       Impact factor: 3.550

3.  Association of MTHFR C677T and A1298C gene polymorphisms with methotrexate efficiency and toxicity in Algerian rheumatoid arthritis patients.

Authors:  Lilya M Berkani; Fadia Rahal; Ines Allam; Soraya Mouaki Benani; Aïcha Laadjouz; Reda Djidjik
Journal:  Heliyon       Date:  2017-12-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.